ALLMedicine™ Ankylosing Spondylitis Center
Research & Reviews 3,551 results
https://doi.org/10.12659/AJCR.936600
The American Journal of Case Reports; Persaud T, Morgan R et. al.
Jul 2nd, 2022 - BACKGROUND Ankylosing spondylitis (AS) is an immune-mediated chronic inflammatory condition grouped under spondyloarthritis (SpA), which is an umbrella term for a group of interrelated inflammatory rheumatic conditions with characteristic radiogra...
https://clinicaltrials.gov/ct2/show/NCT04436640
Jul 1st, 2022 - The purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA, also known as radiographic axSpa (r-axSpA)) including ankylosing spondylitis (AS) and...
https://clinicaltrials.gov/ct2/show/NCT02281747
Jul 1st, 2022 - Major orthopedic procedures, including total joint replacement and spine surgeries, are among the most common procedures in the population. Learning about how often these surgeries are performed can give indications of whether the treatment of art...
https://clinicaltrials.gov/ct2/show/NCT01422694
Jul 1st, 2022 - The purpose of this protocol is to study the natural history of spondyloarthritis (SpA) in children and adults. Spondyloarthritis encompasses a spectrum of immune-mediated inflammatory diseases that exhibit overlapping features, but differ from ot...
https://clinicaltrials.gov/ct2/show/NCT00056719
Jul 1st, 2022 - The susceptibility to ankylosing spondylitis (AS) is largely genetically determined. Recent studies suggest that the severity of AS is also influenced by genetic factors. The goal of this study is to identify genes that influence the severity of A...
Guidelines 11 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.
Aug 23rd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...
https://www.ncbi.nlm.nih.gov/pubmed/30717501
Pain Physician; Kaye AD, Manchikanti L et. al.
Feb 6th, 2019 - Interventional pain management involves diagnosis and treatment of chronic pain. This specialty utilizes minimally invasive procedures to target therapeutics to the central nervous system and the spinal column. A subset of patients encountered in ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779787
Medicine
Mar 6th, 2018 - Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in 2012, but the evidence for these recommendations was only of indirect nature. These recommendations were re-evaluated in light of new insights. Based on the ...
https://doi.org/10.1136/annrheumdis-2016-210770
Annals of the Rheumatic Diseases; van der Heijde D, Ramiro S et. al.
Jan 15th, 2017 - To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one set applicable to the full spectrum of patients with...
https://doi.org/10.1136/annrheumdis-2016-209775
Annals of the Rheumatic Diseases; Agca R, Heslinga SC et. al.
Oct 5th, 2016 - Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European League Against Rheumatism (EULAR) taskforce recommend...
Drugs 836 results see all →
Clinicaltrials.gov 376 results
https://clinicaltrials.gov/ct2/show/NCT04436640
Jul 1st, 2022 - The purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA, also known as radiographic axSpa (r-axSpA)) including ankylosing spondylitis (AS) and...
https://clinicaltrials.gov/ct2/show/NCT01422694
Jul 1st, 2022 - The purpose of this protocol is to study the natural history of spondyloarthritis (SpA) in children and adults. Spondyloarthritis encompasses a spectrum of immune-mediated inflammatory diseases that exhibit overlapping features, but differ from ot...
https://clinicaltrials.gov/ct2/show/NCT02281747
Jul 1st, 2022 - Major orthopedic procedures, including total joint replacement and spine surgeries, are among the most common procedures in the population. Learning about how often these surgeries are performed can give indications of whether the treatment of art...
https://clinicaltrials.gov/ct2/show/NCT00085995
Jul 1st, 2022 - Spinal fusion is the clinical, radiological, and pathological hallmark of ankylosing spondylitis (AS). However, spinal fusion occurs slowly in AS. Serial radiographs rarely show changes over 2 years, and often 5 or more years are needed to demonst...
https://clinicaltrials.gov/ct2/show/NCT00056719
Jul 1st, 2022 - The susceptibility to ankylosing spondylitis (AS) is largely genetically determined. Recent studies suggest that the severity of AS is also influenced by genetic factors. The goal of this study is to identify genes that influence the severity of A...
News 769 results
https://www.medscape.com/viewarticle/976286
Jun 28th, 2022 - Aiming for a disease activity target while reducing biologic therapy could be a winning approach for patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), according to the results of a new study presented at the annual Europ...
https://www.medscape.com/viewarticle/976301
Jun 28th, 2022 - Upadacitinib may soon be used for the treatment of nonradiographic axial spondyloarthritis (nr-axSpA) after the European Medicines Agency's Committee for Medicinal Products for Human Use gave it its stamp of approval last week. AbbVie, the drug's ...
https://www.mdedge.com/rheumatology/article/255773/psoriatic-arthritis/treat-target-strategy-tapering-proves-effective-psa
Thomas R. Collins
Jun 27th, 2022 - Aiming for a disease activity target while reducing biologic therapy could be a winning approach for patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), according to the results of a new study presented at the annual Europ.
https://www.mdedge.com/dermatology/article/255601/psoriatic-arthritis/current-psoriatic-lesions-or-personal-history
Jun 22nd, 2022 - Key clinical point: Patients with psoriatic arthritis (PsA) who had a personal history of psoriasis (pPsA) or a family history of psoriasis and current psoriatic lesions (fPsA/PSO) showed a higher disease activity (DA) and more severe axial joint.
https://www.mdedge.com/neurology/msresourcecenter/article/255251/multiple-sclerosis/sex-differences-ms
Patricia K. Coyle, MD, FAAN, FANA
Jun 14th, 2022 - Dr. Coyle is Professor and Vice Chair (Clinical Affairs), Director, MS Comprehensive Care Center, Stony Brook University Hospital, Stony Brook, NY.